(Total Views: 329)
Posted On: 06/08/2023 12:37:41 PM
Post# of 495
Nice pr today and a timeline to submit the full PMA package. What I conclude is the pps has increased while I was acquiring more shares averaging my pps down. Thats cool! As for Brian Thom our CEO he is a former Citibank VP with experience in mergers and acquisitions.
More new money coming into the UEEC market!
https://www.biospace.com/news/?Keywords=ueec
Full text of the announcement
United Health Products Reiterates Guidance on FDA PMA Application Process
4:34 PM ET 6/7/23 | GlobeNewswire
United Health Products Reiterates Guidance on FDA PMA Application Process
MESQUITE, NV, June 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
As disclosed in a press release on March 29, 2023, UHP has produced additional batches of its HemoStyp hemostatic gauze to demonstrate consistency and uniformity of its manufacturing process as required for Class III medical devices. Testing of these additional batches has produced satisfactory results which have been incorporated into the company's PMA application file.
Concurrently with this effort, packaged product testing in collaboration with the company's U.S. based, FDA certified packaging partner is being conducted to confirm packaging integrity, effective sterilization and other criteria for Class III products. This testing process is advancing as expected and the company anticipates its completion during the month of June as previously stated. Upon completion, the results will also be incorporated into the PMA application and the full application will be submitted to the FDA.
More new money coming into the UEEC market!
https://www.biospace.com/news/?Keywords=ueec
Full text of the announcement
United Health Products Reiterates Guidance on FDA PMA Application Process
4:34 PM ET 6/7/23 | GlobeNewswire
United Health Products Reiterates Guidance on FDA PMA Application Process
MESQUITE, NV, June 07, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- United Health Products, Inc. (OTCPK: UEEC) today provided an update on the company's FDA Premarket Approval application process.
As disclosed in a press release on March 29, 2023, UHP has produced additional batches of its HemoStyp hemostatic gauze to demonstrate consistency and uniformity of its manufacturing process as required for Class III medical devices. Testing of these additional batches has produced satisfactory results which have been incorporated into the company's PMA application file.
Concurrently with this effort, packaged product testing in collaboration with the company's U.S. based, FDA certified packaging partner is being conducted to confirm packaging integrity, effective sterilization and other criteria for Class III products. This testing process is advancing as expected and the company anticipates its completion during the month of June as previously stated. Upon completion, the results will also be incorporated into the PMA application and the full application will be submitted to the FDA.
(0)
(0)Scroll down for more posts ▼
